Figure 3.

Kaplan-Meier survival curves. (A and B) HCC with CK19 expression had a significantly poorer prognosis in terms of (A) DFS and (B) OS; (C) HCC with CDH17 expression had a significantly worse DFS. (D) However, the OS was comparable to those without CDH17 expression; (E) HCC with dual CK19 and CDH17 expressions had a worst prognosis in terms of DFS. (F) The OS was comparable to those with either single positive or dual negative HCC. HCC, hepatocellular carcinoma; CK19, cytokeratin 19; DFS, disease-free survival; OS, overall survival; CDH17, cadherin 17.